About the Psoriatic Arthritis Working Group
Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease occurring in 7–42% of patients with psoriasis. Arthritis, enthesitis, dactylitis, spondylitis, and skin disease result in pain, stiffness, reduced mobility, impairment in physical function, and subsequent disability. PsA is now recognized as a disease that can be serious and progressive despite treatment, resulting in significant physical, psychological, functional, and social impairment.
The updated PsA Core Domain Set was endorsed at OMERACT 2016. Next steps for the PsA working group include evaluation of PsA outcome measures and development of a PsA Core Outcome Measurement Set
Dafna Gladman
Co-Chair
Katy Leung
Co-Chair
Ana-Maria Orbai
Co-Chair
William Tillett
Co-Chair
Niti Goel
Patient Research Partner
Anna Antony - Fellow
Heidi Bertheussen - Patient Research Partner
Lori Schick - Patient Research Partner
Instrument Selection Presentation: Physical function domain for Psoriatic Arthritis (HAQ-DI & SF-36 PF)
OMERACT Endorsed Core Domain Set for Psoriatic Arthritis
OMERACT INSTRUMENT SELECTION CERTIFICATES
Working Group Publications
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016
Enhanced patient involvement and the need to revise the core set- report from the Psoriatic Arthritis working group at OMERACT 2014
Development of a Disease Activity and Responder Index for PsA — Report of the PsA Module at OMERACT 11
Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) — Report of the OMERACT 10 PsA Special Interest Group
Consensus on a Core Set of Domains for PsA
Outcome Measures in PsA
Outcome Measures in Psoriatic Arthritis
Working Group Members:
Adewale Adebajo
Adrien Nzeusseu Toukap
Alexis Ogdie
Alireza Meysami
Ana-Maria Orbai
Andre Ribeiro
Anetta Chrzanowska
Anna Antony
Anupam Wakhlu
Ashish Mathew
Aya Akmal Amin
Beverly Shea
Carlos Guillen Astete
Chris Lindsay
Christine Lindsay
Clifton (Bing) Bingham
Conor Coyle
Dafna Gladman
Denis O'Sullivan
Denise Bury
Desiree van der Heijde
Fernando Pimentel-Santos
Francesco Caso
Gary Choque
Gehad Maghraby
George Bruyn
Ghaydaa Dabie
Gizem Ayan
Heidi Bertheussen
Ilfita Sahbudin
Ingrid Moller Parera
Ingrid Steinkoenig
Ionut Pintilie
Jane Hayes
Jeffrey Chau
Jo Merola
Joao Dias
Jose Alexandre Mendonca
Kate smith
Kenta Misaki
Khaled Abdelgalil
Khalid Alnaqbi
Kristina Duffin
Kristina Harris
Kyung Min Ko
Lara Fallon
Latika Gupta
Laura Coates
Laure Gossec
Lihi Eder
Lori Schick
Maarten de Wit
Maria Antonietta d'Agostino
Maria Sofia Ciliento
Maria Teresa Romero de Albrecht
Maria-Sole Chimenti
Mary Cowern
Mary Holland
Maxine Isbel
Michel Yazbek
Mikael Boesen
Mirco Magnani
Neil McHugh
Nino Tsiskarishvili
Niti Goel
Nouran Abaza
Oliver Fitzgerald
Peter Nash
Peter Tugwell
Philip Helliwell
Philip Mease
Philippe Carron
Pil Hojgaard
Raouf Hajji
Rebecca Sweet
Richard Holland
Robin Christensen
Russka Shumnalieva
Salih Ozgocmen
Sasikala Bheemireddy
Shawna Grosskleg
Simon Stones
Stuart O´Sullivan
Sukhumunni Johal
Tamer Gheita
Tania Elena Gudu
Teresa Clavaguera
Terry Lowdon
Tommy Kok Annfeldt
Tuncay Duruoz
Umut Kalyoncu
Vanessa Ocampo
Vibeke Strand
Walter Maksymowych
Willemina Campbell
William Tillett
Ying Ying (Katy) Leung